2007
DOI: 10.1097/01.sla.0000259391.84304.2b
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Resection Status on Pattern of Failure and Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma

Abstract: There was no statistically significant difference in patient survival or recurrence based on R status. However, this series is unique in the incorporation of a standardized surgical technique for the SMA dissection, the prospective use of a reproducible system for pathologic evaluation of resection margins, the absence of R2 resections, and the frequent use of multimodality therapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

24
397
5
14

Year Published

2008
2008
2019
2019

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 529 publications
(440 citation statements)
references
References 52 publications
24
397
5
14
Order By: Relevance
“…Insufficient examination of the Although most investigators report overall resection margin involvement to be an independent prognostic factor, some have concluded otherwise. [15][16][17].…”
Section: Discussionmentioning
confidence: 99%
“…Insufficient examination of the Although most investigators report overall resection margin involvement to be an independent prognostic factor, some have concluded otherwise. [15][16][17].…”
Section: Discussionmentioning
confidence: 99%
“…Patients with American Joint Committee on Cancer (AJCC) stages I and II pancreatic adenocarcinoma and who are treated with multimodality therapy, including surgery, have a median survival period that may exceed 2 years as well as a potential for cure (34). However, surgery is not an option for patients who initially present with locally advanced (AJCC stage III) disease and who have a reported median survival period of less than 12 months (35).…”
Section: Discussionmentioning
confidence: 99%
“…Auffallenderweise unterscheiden sich internationale Studien signifikant in ihren R1-Raten mit großen Schwankungsbreiten von 20-80 % bei nur gering variierenden patienten-und tumorbezogenen Merkmalen [5,8,15,33,40]. Diese Unterschiede sind auf einen fehlenden Konsens hinsichtlich der Definition des R-Status beim Pankreaskarzinom zurückzuführen.…”
Section: Pankreaskarzinomunclassified